Search results for: 'experiments design'

As clinical pipelines globally witness a surge in novel complex therapies, the clinical trial industry demands new tools in predictive analytics to improve trial design, planning, and execution. Artificial intelligence is gaining large-scale recognition as support for decentralized trial designs, thus enabling patient-centric clinical trial designs...

13 Oct 2020  |  North America  |  Market Research

Increasing Adoption of Low-cost Devices with Simple Designs in Response to COVID-19 to Disrupt the US & EU-5 Ventilator Market, 2025

Rising Preference for Home-based Care, Aided by Remote Monitoring Technologies, to Drive New Growth Opportunities

Infographics

×

Revenue for the US & EU-5 ventilators market is expected to increase by 370.7% in 2020 driven by the ongoing Coronavirus 2019 (COVID-19) situation. The home care segment is expected to see a comparatively strong growth potential post-pandemic. This study assesses the revenue growth impact on different ventilator market segments. It also analyzes fu...

27 Nov 2019  |  North America  |  Market Research

Global Contract Research Organization (CRO) Market, Forecast to 2024

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Infographics

×

Key Issues Addressed

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape. Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the indust...

28 Feb 2022  |  North America  |  Market Research

Growth Opportunities for Platform Approaches in Healthcare, Global

Digital Technologies, User Experience, and Clinical Expertise Will Drive Transformational Growth

Infographics

×

Despite being one of the largest and fastest-growing industries, healthcare is too often slow to innovate. Healthcare services and data are both extremely fragmented, often work in silos, create process inefficiencies, and constrain access and affordability. Digital platforms offer integration and interoperability between applications and solut...

The value-based care (VBC) model aims to offer better outcomes and care quality to patients cost-effectively. Multiple stakeholders, including payers, healthcare providers, and medical technology (medtech) players, can share the revenue risk and incentive for providing better value. The United States is a pioneer in VBC adoption, followed by countr...

24 Jan 2023  |  North America  |  Market Research

US Healthcare Claims Management Growth Opportunities

Intelligent Tools to Automate Payer and Provider Functions Will Boost Efficiency and Deliver a Digital Customer Experience

Infographics

×

The healthcare claims management industry is evolving. Changes include a shifting reimbursement landscape (for virtual care, urgent care, telehealth, and at-home care); a transition to new, value-based care models (e.g., population-based reimbursement and partial and full capitation payment); and disruption from big tech companies, big-box retailer...

Frost & Sullivan’s recent global annual cloud survey’s primary goal is to determine cloud computing technology adoption among healthcare organizations, top business strategic goals, preferred cloud deployment models, information technology (IT), business challenges in cloud migration, and expansion opportunities for healthcare cloud providers. F...

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...